Physician Assistant · Fort Myers, FL
NPI
1992007280
Since 2010
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
12580 University Dr, Suite 200
Fort Myers, FL, 33907
Phone (239) 274-0005
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
2,703 services
Medicare patients, 2024
407
Average age 75
Drug cost, 2024
$938K
1,185 prescriptions
Company payments, 2025
$8,914
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Enid B Martinez was code 17003 (destruction skin lesion), 1,137 times for 183 patients. In total Enid B Martinez billed 2,703 services in 43 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,137 | 183 | $4.39 | $4,992 |
| 99213 Office E&M - Established | Office | 357 | 251 | $57.52 | $21K |
| 17000 Destruction Skin Lesion | Office | 347 | 239 | $30.16 | $10K |
| 11102 Skin Biopsy | Office | 273 | 209 | $60.48 | $17K |
| 99212 Office E&M - Established | Office | 136 | 120 | $34.02 | $4,627 |
| 11103 Skin Biopsy | Office | 110 | 77 | $35.40 | $3,894 |
| 17110 Destruction Skin Lesion | Office | 75 | 66 | $67.89 | $5,092 |
| 99203 Office E&M - New | Office | 47 | 47 | $76.51 | $3,596 |
| 99202 Office E&M - New | Office | 39 | 39 | $35.98 | $1,403 |
| 17262 Destruction Skin Lesion | Office | 36 | 30 | $110.61 | $3,982 |
| 17004 Destruction Skin Lesion | Office | 17 | 14 | $92.18 | $1,567 |
| 17272 Destruction Skin Lesion | Office | 17 | 15 | $128.33 | $2,182 |
| 69100 Other Organ Systems | Office | 14 | 12 | $40.16 | $562 |
By year: 2022 $88K for 2,840 services; 2023 $81K for 2,659 services; 2024 $88K for 2,703 services.
Medicare prescription drug claims, 2024
In 2024, the drug Enid B Martinez prescribed most often to Medicare patients was Triamcinolone Acetonide, with 149 prescriptions and refills. In total Enid B Martinez wrote 1,185 Medicare prescriptions that cost $938K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 149 | 161 | 105 | $1,034 |
| Ketoconazole Generic | 109 | 110 | 56 | $1,423 |
| Clobetasol Propionate Generic | 61 | 73 | 38 | $2,472 |
| Fluorouracil Generic | 59 | 60 | 51 | $3,153 |
| Silver Sulfadiazine Generic | 58 | 59 | 37 | $322 |
| Hydrocortisone Generic | 46 | 46 | 31 | $206 |
| Clindamycin Phosphate Generic | 38 | 39 | 24 | $840 |
| Doxycycline Hyclate Generic | 38 | 42 | 22 | $383 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 38 | 41 | 27 | $930 |
| Ssd Silver Sulfadiazine | 37 | 39 | 32 | $309 |
| Cephalexin Generic | 34 | 34 | 33 | $174 |
| Prednisone Generic | 31 | 31 | 19 | $75.94 |
| Mupirocin Generic | 26 | 26 | 24 | $139 |
| Hydroxyzine Hcl Generic | 26 | 42 | Under 11 | $191 |
| Olumiant Baricitinib | 25 | 31 | Under 11 | $109K |
Brand drugs: 242 claims; generic drugs: 943 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Enid B Martinez $8,914 ($8,914 in general payments such as food, travel and fees) from 20 companies. The largest payer was Pfizer Inc. with $3,134.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 14 | $3,134 |
| Arcutis Biotherapeutics, Inc. ARQT | 20 | $847 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 13 | $818 |
| Janssen Biotech, Inc. JNJ | 15 | $780 |
| Abbvie Inc. ABBV | 28 | $715 |
| UCB, Inc. UCB.BR | 7 | $459 |
| Galderma Laboratories, L.P. GALD.SW | 6 | $320 |
| LEO Pharma Inc. | 6 | $310 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $301 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $300 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.